Clinical Trial Update: Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating veliparib in combination with carboplatin and paclitaxel for locally advanced or metastatic solid tumors. The study includes bre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Veliparib (veliparib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Solid Neoplasm, Estrogen Receptor Negative | Phase 1 | Status: COMPLETED